These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 21335363)

  • 1. Expression of somatostatin receptors, dopamine D₂ receptors, noradrenaline transporters, and vesicular monoamine transporters in 52 pheochromocytomas and paragangliomas.
    Saveanu A; Muresan M; De Micco C; Taieb D; Germanetti AL; Sebag F; Henry JF; Brunaud L; Enjalbert A; Weryha G; Barlier A
    Endocr Relat Cancer; 2011 Apr; 18(2):287-300. PubMed ID: 21335363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 6-18F-fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to 123I-metaiodobenzyl-guanidine scintigraphy in the detection of extraadrenal and hereditary pheochromocytomas and paragangliomas: correlation with vesicular monoamine transporter expression.
    Fottner C; Helisch A; Anlauf M; Rossmann H; Musholt TJ; Kreft A; Schadmand-Fischer S; Bartenstein P; Lackner KJ; Klöppel G; Schreckenberger M; Weber MM
    J Clin Endocrinol Metab; 2010 Jun; 95(6):2800-10. PubMed ID: 20371665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The analysis of quantitative expression of somatostatin and dopamine receptors in gastro-entero-pancreatic tumours opens new therapeutic strategies.
    O'Toole D; Saveanu A; Couvelard A; Gunz G; Enjalbert A; Jaquet P; Ruszniewski P; Barlier A
    Eur J Endocrinol; 2006 Dec; 155(6):849-57. PubMed ID: 17132755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative gene expression of somatostatin receptors and noradrenaline transporter underlying scintigraphic results in patients with neuroendocrine tumors.
    Binderup T; Knigge U; Mellon Mogensen A; Palnaes Hansen C; Kjaer A
    Neuroendocrinology; 2008; 87(4):223-32. PubMed ID: 18196892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential regulation of human dopamine D2 and somatostatin receptor subtype expression by glucocorticoids in vitro.
    de Bruin C; Feelders RA; Waaijers AM; van Koetsveld PM; Sprij-Mooij DM; Lamberts SW; Hofland LJ
    J Mol Endocrinol; 2009 Jan; 42(1):47-56. PubMed ID: 18852217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression of the human somatostatin receptor subtypes sst1 to sst5 in various adrenal tumors and normal adrenal gland.
    Ueberberg B; Tourne H; Redmann A; Walz MK; Schmid KW; Mann K; Petersenn S
    Horm Metab Res; 2005 Dec; 37(12):722-8. PubMed ID: 16372224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can quantification of VMAT and SSTR expression be helpful for planning radionuclide therapy of malignant pheochromocytomas?
    Kölby L; Bernhardt P; Johanson V; Wängberg B; Muth A; Jansson S; Forssell-Aronsson E; Nilsson O; Ahlman H
    Ann N Y Acad Sci; 2006 Aug; 1073():491-7. PubMed ID: 17102116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatostatin and somatostatin receptors: from basic concepts to clinical applications.
    De Martino MC; Hofland LJ; Lamberts SW
    Prog Brain Res; 2010; 182():255-80. PubMed ID: 20541669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Somatostatin Analogs and Dopamine Agonists on Insulin-Like Growth Factor 2-Induced Insulin Receptor Isoform A Activation by Gastroenteropancreatic Neuroendocrine Tumor Cells.
    van Adrichem RC; de Herder WW; Kamp K; Brugts MP; de Krijger RR; Sprij-Mooij DM; Lamberts SW; van Koetsveld PM; Janssen JA; Hofland LJ
    Neuroendocrinology; 2016; 103(6):815-25. PubMed ID: 26836610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of somatostatin and dopamine D2 receptors in endocrine tumors.
    Gatto F; Hofland LJ
    Endocr Relat Cancer; 2011 Dec; 18(6):R233-51. PubMed ID: 22135243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Somatic mutations in H-RAS in sporadic pheochromocytoma and paraganglioma identified by exome sequencing.
    Crona J; Delgado Verdugo A; Maharjan R; Stålberg P; Granberg D; Hellman P; Björklund P
    J Clin Endocrinol Metab; 2013 Jul; 98(7):E1266-71. PubMed ID: 23640968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crucial role for somatostatin receptor subtype 2 in determining the uptake of [111In-DTPA-D-Phe1]octreotide in somatostatin receptor-positive organs.
    Hofland LJ; Lamberts SW; van Hagen PM; Reubi JC; Schaeffer J; Waaijers M; van Koetsveld PM; Srinivasan A; Krenning EP; Breeman WA
    J Nucl Med; 2003 Aug; 44(8):1315-21. PubMed ID: 12902423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coexpression of dopamine and somatostatin receptor subtypes in corticotroph adenomas.
    de Bruin C; Pereira AM; Feelders RA; Romijn JA; Roelfsema F; Sprij-Mooij DM; van Aken MO; van der Lelij AJ; de Herder WW; Lamberts SW; Hofland LJ
    J Clin Endocrinol Metab; 2009 Apr; 94(4):1118-24. PubMed ID: 19141584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RT-PCR and immunocytochemistry studies support the presence of somatostatin, cortistatin and somatostatin receptor subtypes in rat Kupffer cells.
    Xidakis C; Mastrodimou N; Notas G; Renieri E; Kolios G; Kouroumalis E; Thermos K
    Regul Pept; 2007 Oct; 143(1-3):76-82. PubMed ID: 17481746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of Somatostatin, cortistatin, and their receptors, as well as dopamine receptors, but not of neprilysin, are reduced in the temporal lobe of Alzheimer's disease patients.
    Gahete MD; Rubio A; Durán-Prado M; Avila J; Luque RM; Castaño JP
    J Alzheimers Dis; 2010; 20(2):465-75. PubMed ID: 20164562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pituitary tumours: the sst/D2 receptors as molecular targets.
    Hofland LJ; Feelders RA; de Herder WW; Lamberts SW
    Mol Cell Endocrinol; 2010 Sep; 326(1-2):89-98. PubMed ID: 20438803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catecholamine metabolism in paraganglioma and pheochromocytoma: similar tumors in different sites?
    Grouzmann E; Tschopp O; Triponez F; Matter M; Bilz S; Brändle M; Drechser T; Sigrist S; Zulewski H; Henzen C; Fischli S; Abid K
    PLoS One; 2015; 10(5):e0125426. PubMed ID: 25946206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of somatostatins in gastroenteropancreatic neuroendocrine tumor development and therapy.
    Oberg KE; Reubi JC; Kwekkeboom DJ; Krenning EP
    Gastroenterology; 2010 Sep; 139(3):742-53, 753.e1. PubMed ID: 20637207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Somatostatin Receptors and Analogs in Pheochromocytoma and Paraganglioma: Old Players in a New Precision Medicine World.
    Patel M; Tena I; Jha A; Taieb D; Pacak K
    Front Endocrinol (Lausanne); 2021; 12():625312. PubMed ID: 33854479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of the insulin-like growth factor 1 receptor (IGF-1R) is associated with malignancy in familial pheochromocytomas and paragangliomas.
    Fernandez MC; Martin A; Venara M; Calcagno Mde L; Sansó G; Quintana S; Chemes HE; Barontini M; Pennisi PA
    Clin Endocrinol (Oxf); 2013 Nov; 79(5):623-30. PubMed ID: 23506534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.